Search




Research outputs

Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: A survey within the MINDACT cohort   [2023]

Cardozo, Josephine MN; Veira, Sherylene E.; Hassou, Laila Ait; Uwiana, Aime´ Lambert; Božović-Spasojević, Ivana; Bogaerts, Jan; Cardoso, Fatima

Impact of body mass index (BMI) on pathological response after neoadjuvant therapy (NAT) in patients with hormone receptor (HR) and HER2 positive early breast cancer (eBC) - single center experience   [2025]

Djurmez, O; Calamac, M; Dimitrijevic, M; Minic, I; Oblakovic-Babic, J; Serovic, K; Stanic, N; Mihajlovic, S; Gavrilovic, D; Bozovic-Spasojevic, I

PO125 Influence of HER2 status on metastatic pattern in postmenopausal hormone receptor positive breast cancer patients treated with adjuvant tamoxifen only   [2013]

Bozovic Spasojevic I  ; Susnjar Snežana  ; Milović-Kovačević, Marijana  ; Neskovic-Konstantinovic Z  ; Vujasinović Tijana ; Aburabi Zaki ; Milovanovic Zorka  ; Gavrilovic D

Treatment patterns and clinical outcomes according to PD-L1 status in >2000 patients with early-stage or metastatic triple-negative breast cancer treated in the real-world setting: VANESSA study results   [2026]

Popovic, Lazar  ; Barroso-Sousa, Romualdo; El Saghir, Nagi; Dent, Rebecca; Tuzlali, Sitki; Akhtar, Saad; ...; (broj, koautora 18)

P224 Adjuvant Chemotherapy and Disease Outcome in Triple-Negative Breast Cancer: 3-Year Follow-Up Data   [2013]

Susnjar, Snezana V  ; Posarac, Vladan; Milovanovic, Zorka M  ; Milovic-Kovacevic, Marijana M  ; Stamatovic, Ljiljana  ; Gavrilovic, Dusica; Karaferic, Andjela

P104 Menstrual disorders during anthracycline-based adjuvant chemotherapy in very young early breast cancer patients   [2007]

Neskovic-Konstantinovic, Zora B  ; Strbac, D; Susnjar, Snezana V  ; Vukotic, Djordje; Gavrilovic, Dusica

Filters

By type